Selected research
Market Outlook & Growth Opportunities
Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Pre-marital and Pre-Pregnancy Genetic Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pre-marital and Pre-Pregnancy Genetic Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pre-marital and Pre-Pregnancy Genetic Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pre-marital and Pre-Pregnancy Genetic Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pre-marital and Pre-Pregnancy Genetic Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pre-marital and Pre-Pregnancy Genetic Testing Service market include Illumina, Fulgent Genetics, Natera, NxGen MDx, LLC, Sonic Genetics, MedGenome Labs, My Baby Company, Clinical Labs and Eurofins Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Pre-marital and Pre-Pregnancy Genetic Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pre-marital and Pre-Pregnancy Genetic Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pre-marital and Pre-Pregnancy Genetic Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pre-marital and Pre-Pregnancy Genetic Testing Service market.
Pre-marital and Pre-Pregnancy Genetic Testing Service Segment by Company
Illumina
Fulgent Genetics
Natera
NxGen MDx, LLC
Sonic Genetics
MedGenome Labs
My Baby Company
Clinical Labs
Eurofins Scientific
OPKO Health
Gene by Gene
Invitae
Myriad Genetics
Thermo Fisher Scientific
BGI
Berry Genomics
Kingmed Diagnostic
Dian Diagnostics Group
Adicon
Zhongyuan Concord
WuXi AppTec
Novogene
AmoyDx
Centogene
Genoma Group
SRL Inc.
LSI Medience
GC Genome
Seegene
Huizhi Gene
Pre-marital and Pre-Pregnancy Genetic Testing Service Segment by Type
Premarital Genetic Testing
Preconception Genetic Testing
Pre-marital and Pre-Pregnancy Genetic Testing Service Segment by Application
Premarital Population
Couples Planning for Pregnancy
People with a Family History of Genetic Diseases
People Undergoing Assisted Reproductive Technology (IVF)
Pre-marital and Pre-Pregnancy Genetic Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Pre-marital and Pre-Pregnancy Genetic Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pre-marital and Pre-Pregnancy Genetic Testing Service key companies, revenue, market share, and recent developments.
3. To split the Pre-marital and Pre-Pregnancy Genetic Testing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pre-marital and Pre-Pregnancy Genetic Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pre-marital and Pre-Pregnancy Genetic Testing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Pre-marital and Pre-Pregnancy Genetic Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-marital and Pre-Pregnancy Genetic Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pre-marital and Pre-Pregnancy Genetic Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-marital and Pre-Pregnancy Genetic Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pre-marital and Pre-Pregnancy Genetic Testing Service industry.
Chapter 3: Detailed analysis of Pre-marital and Pre-Pregnancy Genetic Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pre-marital and Pre-Pregnancy Genetic Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pre-marital and Pre-Pregnancy Genetic Testing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Premarital Genetic Testing
- Preconception Genetic Testing
Applications
- Premarital Population
- Couples Planning for Pregnancy
- People with a Family History of Genetic Diseases
- People Undergoing Assisted Reproductive Technology (IVF)
Companies covered
- Illumina
- Fulgent Genetics
- Natera
- NxGen MDx, LLC
- Sonic Genetics
- MedGenome Labs
- My Baby Company
- Clinical Labs
- Eurofins Scientific
- OPKO Health
- Gene by Gene
- Invitae
- Myriad Genetics
- Thermo Fisher Scientific
- BGI
- Berry Genomics
- Kingmed Diagnostic
- Dian Diagnostics Group
- Adicon
- Zhongyuan Concord
- WuXi AppTec
- Novogene
- AmoyDx
- Centogene
- Genoma Group
- SRL Inc.
- LSI Medience
- GC Genome
- Seegene
- Huizhi Gene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pre-marital and Pre-Pregnancy Genetic Testing Service Market Dynamics
- 2.1 Pre-marital and Pre-Pregnancy Genetic Testing Service Industry Trends
- 2.2 Pre-marital and Pre-Pregnancy Genetic Testing Service Industry Drivers
- 2.3 Pre-marital and Pre-Pregnancy Genetic Testing Service Industry Opportunities and Challenges
- 2.4 Pre-marital and Pre-Pregnancy Genetic Testing Service Industry Restraints
3 Pre-marital and Pre-Pregnancy Genetic Testing Service Market by Company
- 3.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Company Revenue Ranking in 2025
- 3.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue by Company (2021-2026)
- 3.3 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Company Ranking (2024-2026)
- 3.4 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Company Manufacturing Base and Headquarters
- 3.5 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Company Product Type and Application
- 3.6 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pre-marital and Pre-Pregnancy Genetic Testing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pre-marital and Pre-Pregnancy Genetic Testing Service Market by Type
- 4.1 Pre-marital and Pre-Pregnancy Genetic Testing Service Type Introduction
- 4.1.1 Premarital Genetic Testing
- 4.1.2 Preconception Genetic Testing
- 4.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Type
- 4.2.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Type (2021-2032)
- 4.2.3 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type (2021-2032)
5 Pre-marital and Pre-Pregnancy Genetic Testing Service Market by Application
- 5.1 Pre-marital and Pre-Pregnancy Genetic Testing Service Application Introduction
- 5.1.1 Premarital Population
- 5.1.2 Couples Planning for Pregnancy
- 5.1.3 People with a Family History of Genetic Diseases
- 5.1.4 People Undergoing Assisted Reproductive Technology (IVF)
- 5.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Application
- 5.2.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Application (2021-2032)
- 5.2.3 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application (2021-2032)
6 Pre-marital and Pre-Pregnancy Genetic Testing Service Regional Value Analysis
- 6.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Region (2021-2032)
- 6.2.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Region: 2021-2026
- 6.2.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value (2021-2032)
- 6.3.2 North America Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value (2021-2032)
- 6.4.2 Europe Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value (2021-2032)
- 6.6.2 South America Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Country, 2025 VS 2032
7 Pre-marital and Pre-Pregnancy Genetic Testing Service Country-level Value Analysis
- 7.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Country (2021-2032)
- 7.2.1 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Country (2021-2026)
- 7.2.2 Global Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pre-marital and Pre-Pregnancy Genetic Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Illumina
- 8.1.1 Illumina Company Information
- 8.1.2 Illumina Business Overview
- 8.1.3 Illumina Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Illumina Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.1.5 Illumina Recent Developments
- 8.2 Fulgent Genetics
- 8.2.1 Fulgent Genetics Company Information
- 8.2.2 Fulgent Genetics Business Overview
- 8.2.3 Fulgent Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Fulgent Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.2.5 Fulgent Genetics Recent Developments
- 8.3 Natera
- 8.3.1 Natera Company Information
- 8.3.2 Natera Business Overview
- 8.3.3 Natera Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Natera Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.3.5 Natera Recent Developments
- 8.4 NxGen MDx, LLC
- 8.4.1 NxGen MDx, LLC Company Information
- 8.4.2 NxGen MDx, LLC Business Overview
- 8.4.3 NxGen MDx, LLC Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 NxGen MDx, LLC Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.4.5 NxGen MDx, LLC Recent Developments
- 8.5 Sonic Genetics
- 8.5.1 Sonic Genetics Company Information
- 8.5.2 Sonic Genetics Business Overview
- 8.5.3 Sonic Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Sonic Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.5.5 Sonic Genetics Recent Developments
- 8.6 MedGenome Labs
- 8.6.1 MedGenome Labs Company Information
- 8.6.2 MedGenome Labs Business Overview
- 8.6.3 MedGenome Labs Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 MedGenome Labs Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.6.5 MedGenome Labs Recent Developments
- 8.7 My Baby Company
- 8.7.1 My Baby Company Company Information
- 8.7.2 My Baby Company Business Overview
- 8.7.3 My Baby Company Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 My Baby Company Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.7.5 My Baby Company Recent Developments
- 8.8 Clinical Labs
- 8.8.1 Clinical Labs Company Information
- 8.8.2 Clinical Labs Business Overview
- 8.8.3 Clinical Labs Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Clinical Labs Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.8.5 Clinical Labs Recent Developments
- 8.9 Eurofins Scientific
- 8.9.1 Eurofins Scientific Company Information
- 8.9.2 Eurofins Scientific Business Overview
- 8.9.3 Eurofins Scientific Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Eurofins Scientific Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.9.5 Eurofins Scientific Recent Developments
- 8.10 OPKO Health
- 8.10.1 OPKO Health Company Information
- 8.10.2 OPKO Health Business Overview
- 8.10.3 OPKO Health Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 OPKO Health Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.10.5 OPKO Health Recent Developments
- 8.11 Gene by Gene
- 8.11.1 Gene by Gene Company Information
- 8.11.2 Gene by Gene Business Overview
- 8.11.3 Gene by Gene Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Gene by Gene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.11.5 Gene by Gene Recent Developments
- 8.12 Invitae
- 8.12.1 Invitae Company Information
- 8.12.2 Invitae Business Overview
- 8.12.3 Invitae Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Invitae Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.12.5 Invitae Recent Developments
- 8.13 Myriad Genetics
- 8.13.1 Myriad Genetics Company Information
- 8.13.2 Myriad Genetics Business Overview
- 8.13.3 Myriad Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Myriad Genetics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.13.5 Myriad Genetics Recent Developments
- 8.14 Thermo Fisher Scientific
- 8.14.1 Thermo Fisher Scientific Company Information
- 8.14.2 Thermo Fisher Scientific Business Overview
- 8.14.3 Thermo Fisher Scientific Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.14.4 Thermo Fisher Scientific Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.14.5 Thermo Fisher Scientific Recent Developments
- 8.15 BGI
- 8.15.1 BGI Company Information
- 8.15.2 BGI Business Overview
- 8.15.3 BGI Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.15.4 BGI Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.15.5 BGI Recent Developments
- 8.16 Berry Genomics
- 8.16.1 Berry Genomics Company Information
- 8.16.2 Berry Genomics Business Overview
- 8.16.3 Berry Genomics Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.16.4 Berry Genomics Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.16.5 Berry Genomics Recent Developments
- 8.17 Kingmed Diagnostic
- 8.17.1 Kingmed Diagnostic Company Information
- 8.17.2 Kingmed Diagnostic Business Overview
- 8.17.3 Kingmed Diagnostic Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.17.4 Kingmed Diagnostic Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.17.5 Kingmed Diagnostic Recent Developments
- 8.18 Dian Diagnostics Group
- 8.18.1 Dian Diagnostics Group Company Information
- 8.18.2 Dian Diagnostics Group Business Overview
- 8.18.3 Dian Diagnostics Group Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.18.4 Dian Diagnostics Group Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.18.5 Dian Diagnostics Group Recent Developments
- 8.19 Adicon
- 8.19.1 Adicon Company Information
- 8.19.2 Adicon Business Overview
- 8.19.3 Adicon Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.19.4 Adicon Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.19.5 Adicon Recent Developments
- 8.20 Zhongyuan Concord
- 8.20.1 Zhongyuan Concord Company Information
- 8.20.2 Zhongyuan Concord Business Overview
- 8.20.3 Zhongyuan Concord Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.20.4 Zhongyuan Concord Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.20.5 Zhongyuan Concord Recent Developments
- 8.21 WuXi AppTec
- 8.21.1 WuXi AppTec Company Information
- 8.21.2 WuXi AppTec Business Overview
- 8.21.3 WuXi AppTec Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.21.4 WuXi AppTec Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.21.5 WuXi AppTec Recent Developments
- 8.22 Novogene
- 8.22.1 Novogene Company Information
- 8.22.2 Novogene Business Overview
- 8.22.3 Novogene Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.22.4 Novogene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.22.5 Novogene Recent Developments
- 8.23 AmoyDx
- 8.23.1 AmoyDx Company Information
- 8.23.2 AmoyDx Business Overview
- 8.23.3 AmoyDx Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.23.4 AmoyDx Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.23.5 AmoyDx Recent Developments
- 8.24 Centogene
- 8.24.1 Centogene Company Information
- 8.24.2 Centogene Business Overview
- 8.24.3 Centogene Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.24.4 Centogene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.24.5 Centogene Recent Developments
- 8.25 Genoma Group
- 8.25.1 Genoma Group Company Information
- 8.25.2 Genoma Group Business Overview
- 8.25.3 Genoma Group Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.25.4 Genoma Group Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.25.5 Genoma Group Recent Developments
- 8.26 SRL Inc.
- 8.26.1 SRL Inc. Company Information
- 8.26.2 SRL Inc. Business Overview
- 8.26.3 SRL Inc. Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.26.4 SRL Inc. Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.26.5 SRL Inc. Recent Developments
- 8.27 LSI Medience
- 8.27.1 LSI Medience Company Information
- 8.27.2 LSI Medience Business Overview
- 8.27.3 LSI Medience Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.27.4 LSI Medience Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.27.5 LSI Medience Recent Developments
- 8.28 GC Genome
- 8.28.1 GC Genome Company Information
- 8.28.2 GC Genome Business Overview
- 8.28.3 GC Genome Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.28.4 GC Genome Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.28.5 GC Genome Recent Developments
- 8.29 Seegene
- 8.29.1 Seegene Company Information
- 8.29.2 Seegene Business Overview
- 8.29.3 Seegene Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.29.4 Seegene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.29.5 Seegene Recent Developments
- 8.30 Huizhi Gene
- 8.30.1 Huizhi Gene Company Information
- 8.30.2 Huizhi Gene Business Overview
- 8.30.3 Huizhi Gene Pre-marital and Pre-Pregnancy Genetic Testing Service Revenue and Gross Margin (2021-2026)
- 8.30.4 Huizhi Gene Pre-marital and Pre-Pregnancy Genetic Testing Service Product Portfolio
- 8.30.5 Huizhi Gene Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst